#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kerrie Brady Email
CEO & President . OcuTerra Therapeutics
How to contact Kerrie Brady
Join and see Kerrie's contact info for free!Current Roles
Employees:
12Revenue:
$930kAbout
Non-Invasive, Transformational Approach to Treating Retinal Disease. OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activityOcuTerra Therapeutics Address
50 Milk StreetBoston, MA